Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting.

Adv Ther · 2023 · PMC9988734 · PMID 36515803

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Accordingly, patients in all subgroups had significantly higher odds of achieving these outcomes in the anti-IL-17A cohort relative to the other biologics cohort, except for the Asian subgroup ORs (primary and PASI90), which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.